Larvol Delta - March-Biosciences-and-Cancer-Focus-Fund-Announce-48-Million-Investment-to-Support-a-Phase-2-Clinical-Trial-of-Novel-CART-Therapy-for-TCell-Lymphoma

MB-105 - March Bio

https://www.prnewswire.com/news-releases/march-biosciences-and-cancer-focus-fund-announce-4-8-million-investment-to-support-a-phase-2-clinical-trial-of-novel-car-t-therapy-for-t-cell-lymphoma-301982657.html

Nov 9, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next